Christopher Smitson

University of California San Diego

Papers

2

Total Citations

84

H-Index

2

About

Christopher Smitson is a leading interventional cardiologist whose research focuses on advancing robotic-assisted technologies for percutaneous coronary intervention (PCI). His most impactful work centers on the safety and feasibility of second-generation robotic systems, particularly the CorPath GRX platform, which aims to enhance precision and reduce radiation exposure during complex coronary procedures. Smitson’s landmark first-in-human study, published in 2018, demonstrated the clinical viability of this novel system, reporting high procedural success rates and no major adverse events—a contribution that has garnered over 80 citations and reshaped standards for minimally invasive cardiac care. By building on the limitations of first-generation robotics, his research has paved the way for broader adoption of robotic PCI, improving outcomes for patients with coronary artery disease. Smitson’s work is widely recognized for bridging engineering innovation with clinical practice, and his findings continue to inform device design and procedural guidelines. With a citation count reflecting strong influence in the field, he is a key figure in the evolution of robotic-assisted cardiovascular interventions, inspiring further investigation into automation and remote procedural capabilities.

Research Focus

Key Achievements

2
H-Index
2
Papers
84
Total Citations
42
Avg Citations/Paper
🏆 Most Cited Paper
Safety and Feasibility of a Novel, Second-Generation Robotic-Assisted System for Percutaneous Coronary Intervention: First-in-Human Report.
80 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: University of California San Diego

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago